Scientists have developed a new cancer vaccine with the potential to activate the body’s immune system to fight a range of cancers, including leukaemia, breast cancer, lung cancer and pancreatic cancers.
Scientists are ready to trial a new cancer vaccine in humans following the successful outcome of their preclinical studies.
The new vaccine was developed by a Mater Research team based at The Translational Research Institute in collaboration with The University of Queensland.
Lead Researcher Associate Professor Kristen Radford says the vaccine has the potential to treat a variety of blood cancers ...
Read More
Recent Comments